Strategy for surveying the proteome using affinity proteomics and mass spectrometry
- 17 March 2009
- journal article
- review article
- Published by Wiley in Proteomics
- Vol. 9 (6) , 1511-1517
Abstract
Antibody‐based microarrays is a rapidly evolving technology that has gone from the first proof‐of‐concept studies to more demanding proteome profiling applications, during the last years. Miniaturized microarrays can be printed with large number of antibodies harbouring predetermined specificities, capable of targeting high‐ as well as low‐abundant analytes in complex, nonfractionated proteomes. Consequently, the resolution of such proteome profiling efforts correlate directly to the number of antibodies included, which today is a key limiting factor. To overcome this bottleneck and to be able to perform in‐depth global proteome surveys, we propose to interface affinity proteomics with MS‐based read‐out, as outlined in this technical perspective. Briefly, we have defined a range of peptide motifs, each motif being present in 5–100 different proteins. In this manner, 100 antibodies, binding 100 different motifs commonly distributed among different proteins, would potentially target a protein cluster of 104 individual molecules, i.e. around 50% of the nonredundant human proteome. Notably, these motif‐specific antibodies would be directly applicable to any proteome in a specie independent manner and not biased towards abundant proteins or certain protein classes. The biological sample is digested, exposed to these immobilized antibodies, whereby motif‐containing peptides are specifically captured, enriched and subsequently detected and identified using MS.Keywords
This publication has 49 references indexed in Scilit:
- Synthetic Antibody Libraries Focused Towards Peptide LigandsJournal of Molecular Biology, 2008
- Antibody microarray‐based profiling of complex specimens: systematic evaluation of labeling strategiesProteomics, 2007
- Proteomics in clinical interventions: Achievements and limitations in biomarker developmentLife Sciences, 2007
- Large-Scale Proteomics Analysis of Human Ovarian Cancer for BiomarkersJournal of Proteome Research, 2007
- Contribution of oncoproteomics to cancer biomarker discoveryMolecular Cancer, 2007
- Human body fluid proteome analysisProteomics, 2006
- Antibody Microarrays: Current Status and Key Technological AdvancesOMICS: A Journal of Integrative Biology, 2006
- Antibody microarray-based oncoproteomicsExpert Opinion on Biological Therapy, 2006
- Multiplexed protein measurement: technologies and applications of protein and antibody arraysNature Reviews Drug Discovery, 2006
- Practical proteomic biomarker discovery: taking a step back to leap forwardDrug Discovery Today, 2005